By modulating critical oncogenic processes such as epithelial–mesenchymal transition via its interactions with the MBD1-Twist-SIRT1 complex, SIRT1 not only influences tumor invasiveness but also impacts chemotherapy sensitivity. The gene discussed is MBD1; the disease is neoplasm.